Radiopharm Theranostics Ltd
RADX$11.94B
Large CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCARLTON VIC14 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
RADX News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
177Lu-BetaBart
Castration-Resistant Prostate Cancer (CRPC)
RAD101 (18F-FPIA)
Brain Metastases From Solid Tumors
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
177Lu-BetaBart | Phase 2 | Castration-Resistant Prostate Cancer (CRPC) | - | - |
RAD101 (18F-FPIA) | Phase 2 | Brain Metastases From Solid Tumors | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply